Emilie Lerstrøm is associated partner in Bruun & Hjejle’s IP & Digital Business department and has more than ten years of experience in the field of IP. She particularly advises on patent law, trade secrets and regulatory conditions in the field of, inter alia, life sciences and the food industry. Emilie also has experience with license agreements and handling IP in research and development agreements.
In addition, Emilie advises on IP in relation to IP heavy transactions, litigates before the Danish courts (including High courts) and advises on various procurement matters within the life science industry. She holds an LL.M. in Innovation Law from the University of New South Wales in Sydney, where she was admitted to the ”Dean’s List of Excellence in Academic Performance” for her results.
Emilie is ranked in the silver category for patent litigation by IAM Patent 1000 and recognised by Lexology with a Client Choice Award.
Highlights (Panel content)
- Represented a Danish life science start-up and its board of directors in strategic advice relative to exiting a patent sales agreement (2025)
- Represented a German innovative cosmetics company in proceedings before the Danish courts relative to product liability claims (2024)
- Assisted an Austrian food supplements company in entering the Danish market (market access, claim clearance, notifications) (2024)
- Represented a Danish life science company in preliminary injunction proceedings before the Danish Maritime and Commercial High Court concerning misappropriation of trade secrets (2024)
- Assisted Contour Design on a number of IP legal conditions in connection with sale of the company to Polaris (2020)
- Assisted a Danish company with IP legal aspects in connection with listing on the First North stock exchange for growth companies (2020)
- Represented a Swedish food supplement company before the Danish Maritime and Commercial High Court on enforcement of the company’s rights in accordance with the Danish Marketing Practices Act (2020)
Medlemskaber (Panel content)
Emilie is a board member of the Danish Life Science Law Association (DALILA).
Publikationer (Panel content)
Contributor to a number of articles on IP strategies in inter alia the Børsen Health Tech magazine and the Berlingske Life Science addendum.